Development of Pharmacodynamic Biomarkers in Circulating Renal Cancer Cells

Dr. Joshua Lang, M.D., M.S. discusses Development of Pharmacodynamic Biomarkers in Circulating Renal Cancer Cells at the Kidney Cancer meeting in Chicago